Elevated epidermal growth factor receptor levels in Barrett’s
esophagus

a 2021

Elevated epidermal growth factor receptor levels in Barrett’s esophagus

DEISSOVÁ, Tereza, Lydie IZAKOVIČOVÁ HOLLÁ, Zuzana ZÁKOSTELSKÁ JIRÁSKOVÁ, Jiří DOLINA, Radek KROUPA et. al.

Základní údaje

Originální název

Elevated epidermal growth factor receptor levels in Barrett’s esophagus

Autoři

DEISSOVÁ, Tereza (203 Česká republika, domácí), Lydie IZAKOVIČOVÁ HOLLÁ (203 Česká republika, domácí), Zuzana ZÁKOSTELSKÁ JIRÁSKOVÁ (203 Česká republika), Jiří DOLINA (203 Česká republika, domácí), Radek KROUPA (203 Česká republika, domácí), Lumír KUNOVSKÝ (203 Česká republika, domácí), Zdeněk PAVLOVSKÝ (203 Česká republika, domácí), Břetislav LIPOVÝ (203 Česká republika, domácí), Zdeněk DANĚK (203 Česká republika, domácí), Zdeněk KALA (203 Česká republika, domácí), Ondřej SLABÝ (203 Česká republika, domácí), Ondřej URBAN (203 Česká republika), Vít NAVRÁTIL (203 Česká republika), Tomáš HARUŠTIAK (203 Česká republika), Robert LISCHKE (203 Česká republika) a Petra BOŘILOVÁ LINHARTOVÁ (203 Česká republika, garant, domácí)

Vydání

UEG Week Virtual 2021, United European Gastroenterology Journal 2021; 9 (Supplement 1), 2021

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30300 3.3 Health sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/21:00120236

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

epidermal growth factor; gastroesophageal reflux; polymorphism; case-control study;

Štítky

rivok

Změněno: 2. 5. 2022 09:08, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: Gastroesophageal reflux disease (GERD) can manifest through various symptoms including mucosal damage, in which case we speak of reflux esophagitis (RE), Barrett’s esophagus (BE) or esophageal adenocarcinoma (EAC). The epidermal growth factor (EGF) and its receptor (EGFR) is pivotal in the maintenance of the integrity of the esophageal mucosa and repair of injured tissues. On the other hand, upregulation of the EGF signaling pathway has been shown to lead to neoplastic transformation; in addition, EGFR expression was also associated with GERD progression.1-8 Aims & methods: The aim of our study was to compare the expression of EGF and EGFR in the esophageal tissues with vs. without pathological changes in GERD patients. The EGF and EGFR mRNA expressions were analyzed by reverse transcription qPCR in 50 fresh esophageal tissue biopsies with/without pathological changes taken from 25 patients with GERD (RE [N=10], BE [N=8], EAC [N=7]). In addition, the EGFR protein expression was examined in 50 corresponding formalin-fixed paraffin esophageal tissues using immunohistochemistry. The mRNA and protein expressions were statistically evaluated using the Wilcoxon signed ranked test in Statistica v13.2. Results: No differences in the EGF or EGFR mRNA expressions in the esophageal tissues with and without pathological changes were detected in neither of the patient groups (p>0.05). However, the EGFR protein levels in BE biopsies were higher than in corresponding samples without metaplastic changes.(p=0.034). Conclusion: Although the study is limited by the small number of patients, our results suggest that EGFR may possibly serve as a biomarker of BE development. This is the first study comparing EGF and its receptor expressions in multiple sites of the esophagus in the same patient with GERD.

Návaznosti

NU20-03-00126, projekt VaV

Název: Hostitelský mikrobiom ve vztahu k rozvoji Barrettova jícnu a adenokarcinomu jícnu

Investor: Ministerstvo zdravotnictví ČR, Hostitelský mikrobiom ve vztahu k rozvoji Barrettova jícnu a adenokarcinomu jícnu, Podprogram 1 - standardní

Citovat

DEISSOVÁ, Tereza, Lydie IZAKOVIČOVÁ HOLLÁ, Zuzana ZÁKOSTELSKÁ JIRÁSKOVÁ, Jiří DOLINA, Radek KROUPA, Lumír KUNOVSKÝ, Zdeněk PAVLOVSKÝ, Břetislav LIPOVÝ, Zdeněk DANĚK, Zdeněk KALA, Ondřej SLABÝ, Ondřej URBAN, Vít NAVRÁTIL, Tomáš HARUŠTIAK, Robert LISCHKE a Petra BOŘILOVÁ LINHARTOVÁ. Elevated epidermal growth factor receptor levels in Barrett’s esophagus. In UEG Week Virtual 2021, United European Gastroenterology Journal 2021; 9 (Supplement 1). 2021.

@proceedings{1840789,
   author = {Deissová, Tereza and Izakovičová Hollá, Lydie and Zákostelská Jirásková, Zuzana and Dolina, Jiří and Kroupa, Radek and Kunovský, Lumír and Pavlovský, Zdeněk and Lipový, Břetislav and Daněk, Zdeněk and Kala, Zdeněk and Slabý, Ondřej and Urban, Ondřej and Navrátil, Vít and Haruštiak, Tomáš and Lischke, Robert and Bořilová Linhartová, Petra},
   booktitle = {UEG Week Virtual 2021, United European Gastroenterology Journal 2021; 9 (Supplement 1)},
   keywords = {epidermal growth factor; gastroesophageal reflux; polymorphism; case-control study;},
   language = {eng},
   title = {Elevated epidermal growth factor receptor levels in Barrett’s esophagus},
   year = {2021}
}

TY  - CONF
ID  - 1840789
AU  - Deissová, Tereza - Izakovičová Hollá, Lydie - Zákostelská Jirásková, Zuzana - Dolina, Jiří - Kroupa, Radek - Kunovský, Lumír - Pavlovský, Zdeněk - Lipový, Břetislav - Daněk, Zdeněk - Kala, Zdeněk - Slabý, Ondřej - Urban, Ondřej - Navrátil, Vít - Haruštiak, Tomáš - Lischke, Robert - Bořilová Linhartová, Petra
PY  - 2021
TI  - Elevated epidermal growth factor receptor levels in Barrett’s esophagus
KW  - epidermal growth factor
KW  - gastroesophageal reflux
KW  - polymorphism
KW  - case-control study;
N2  - Introduction: Gastroesophageal reflux disease (GERD) can manifest through various symptoms including mucosal damage, in which case we speak of reflux esophagitis (RE), Barrett’s esophagus (BE) or esophageal adenocarcinoma (EAC). The epidermal growth factor (EGF) and its receptor (EGFR) is pivotal in the maintenance of the integrity of the esophageal mucosa and repair of injured tissues. On the other hand, upregulation of the EGF signaling pathway has been shown to lead to neoplastic transformation; in addition, EGFR expression was also associated with GERD progression.1-8 Aims & methods: The aim of our study was to compare the expression of EGF and EGFR in the esophageal tissues with vs. without pathological changes in GERD patients. The EGF and EGFR mRNA expressions were analyzed by reverse transcription qPCR in 50 fresh esophageal tissue biopsies with/without pathological changes taken from 25 patients with GERD (RE [N=10], BE [N=8], EAC [N=7]). In addition, the EGFR protein expression was examined in 50 corresponding formalin-fixed paraffin esophageal tissues using immunohistochemistry. The mRNA and protein expressions were statistically evaluated using the Wilcoxon signed ranked test in Statistica v13.2. Results: No differences in the EGF or EGFR mRNA expressions in the esophageal tissues with and without pathological changes were detected in neither of the patient groups (p>0.05). However, the EGFR protein levels in BE biopsies were higher than in corresponding samples without metaplastic changes.(p=0.034). Conclusion: Although the study is limited by the small number of patients, our results suggest that EGFR may possibly serve as a biomarker of BE development. This is the first study comparing EGF and its receptor expressions in multiple sites of the esophagus in the same patient with GERD.
ER  -

DEISSOVÁ, Tereza, Lydie IZAKOVIČOVÁ HOLLÁ, Zuzana ZÁKOSTELSKÁ JIRÁSKOVÁ, Jiří DOLINA, Radek KROUPA, Lumír KUNOVSKÝ, Zdeněk PAVLOVSKÝ, Břetislav LIPOVÝ, Zdeněk DANĚK, Zdeněk KALA, Ondřej SLABÝ, Ondřej URBAN, Vít NAVRÁTIL, Tomáš HARUŠTIAK, Robert LISCHKE a Petra BOŘILOVÁ LINHARTOVÁ. Elevated epidermal growth factor receptor levels in Barrett’s esophagus. In \textit{UEG Week Virtual 2021, United European Gastroenterology Journal 2021; 9 (Supplement 1)}. 2021.

Podrobný výpis o publikaci